V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260006685 | 260004845 | 1.63 | 83 | Disease modification (D) | 2015-09-24 | 2015-09-26 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260024352 | BENDAMUSTINE + RITUXIMAB |
| 260006686 | 260004846 | 1.76 | 78 | Disease modification (D) | 2017-09-13 | 2017-10-19 | BENDAMUSTINE + RITUXIMAB | N | N | 260024358 | BENDAMUSTINE + RITUXIMAB |
| 260006687 | 260004846 | 1.59 | null | Curative (C) | 2016-02-14 | 2016-02-18 | BENDAMUSTINE + RITUXIMAB | null | null | 260024358 | BENDAMUSTINE + RITUXIMAB |
| 260006688 | 260004847 | 1.69 | 87 | Palliative (P) | 2017-01-09 | 2017-01-14 | BENDAMUSTINE + RITUXIMAB | N | N | 260024361 | BENDAMUSTINE + RITUXIMAB |
| 260006689 | 260011353 | null | 71.1 | null | null | 2015-07-15 | BENDAMUSTINE + RITUXIMAB | N | N | 260024362 | BENDAMUSTINE + RITUXIMAB |
| 260006690 | 260011353 | 1.48 | null | Palliative (P) | 2017-11-20 | 2017-11-27 | BENDAMUSTINE + RITUXIMAB | 99 | N | 260024362 | BENDAMUSTINE + RITUXIMAB |
| 260006691 | 260004848 | 1.85 | 87.2 | Curative (C) | 2014-02-24 | 2014-03-02 | Bendamustine+Rituximab (1st Course) | 02 | N | 260024364 | BENDAMUSTINE + RITUXIMAB |
| 260006692 | 260004848 | 1.81 | 80 | Disease modification (D) | 2016-11-09 | 2016-11-17 | BENDAMUSTINE + RITUXIMAB | N | N | 260024364 | BENDAMUSTINE + RITUXIMAB |
| 260006693 | 260004848 | 1.66 | 68 | Palliative (P) | 2016-09-03 | 2016-09-16 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260024364 | BENDAMUSTINE + RITUXIMAB |
| 260006694 | 260004849 | 1.84 | 76.4 | Palliative (P) | 2016-10-20 | 2016-10-30 | Bendamustine+Rituximab (1st Course) | N | N | 260024372 | BENDAMUSTINE + RITUXIMAB |
| 260006695 | 260004849 | 1.7 | 61.2 | Palliative (P) | 2017-09-04 | 2017-09-17 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260024372 | BENDAMUSTINE + RITUXIMAB |
| 260006696 | 260004849 | 1.52 | 70.3 | Palliative (P) | 2015-04-28 | 2015-05-06 | Bendamustine+Rituximab (1st Course) | N | N | 260024372 | BENDAMUSTINE + RITUXIMAB |
| 260006698 | 260004850 | 1.75 | 78.5 | Curative (C) | 2016-10-15 | 2016-10-24 | BENDAMUSTINE + RITUXIMAB | N | N | 260024379 | BENDAMUSTINE + RITUXIMAB |
| 260006699 | 260004851 | null | null | Disease modification (D) | 2016-02-25 | 2016-03-07 | BENDAMUSTINE + RITUXIMAB | N | N | 260024380 | BENDAMUSTINE + RITUXIMAB |
| 260006700 | 260004852 | 1.92 | 82.9 | null | 2017-11-27 | 2017-11-29 | Bendamustine+Rituximab (1st Course) | 02 | N | 260024381 | BENDAMUSTINE + RITUXIMAB |
| 260006701 | 260004852 | 1.69 | 65 | Curative (C) | 2016-10-06 | 2016-10-07 | BENDAMUSTINE + RITUXIMAB | 02 | null | 260024381 | BENDAMUSTINE + RITUXIMAB |
| 260006702 | 260004852 | 1.8 | 88 | Disease modification (D) | null | 2017-02-22 | BENDAMUSTINE + RITUXIMAB | N | N | 260024381 | BENDAMUSTINE + RITUXIMAB |
| 260006703 | 260004853 | 1.71 | 73.3 | Curative (C) | 2013-07-30 | 2013-07-30 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024387 | BENDAMUSTINE + RITUXIMAB |
| 260006704 | 260004853 | null | null | Curative (C) | 2014-11-25 | 2014-11-26 | BENDAMUSTINE + RITUXIMAB | N | N | 260024387 | BENDAMUSTINE + RITUXIMAB |
| 260006705 | 260004853 | 1.73 | 80.4 | null | 2016-03-20 | 2016-03-26 | BENDAMUSTINE + RITUXIMAB | N | null | 260024387 | BENDAMUSTINE + RITUXIMAB |
| 260006706 | 260004854 | null | 90 | Curative (C) | 2013-03-16 | 2013-03-19 | BENDAMUSTINE + RITUXIMAB | N | null | 260024391 | BENDAMUSTINE + RITUXIMAB |
| 260006707 | 260004855 | 1.64 | 61 | Disease modification (D) | 2014-02-02 | 2014-02-11 | Bendamustine+Rituximab (1st Course) | N | N | 260024392 | BENDAMUSTINE + RITUXIMAB |
| 260006708 | 260004855 | 1.76 | 119.7 | Disease modification (D) | 2015-04-14 | 2015-04-16 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024392 | BENDAMUSTINE + RITUXIMAB |
| 260006709 | 260004856 | 1.63 | 63 | Palliative (P) | 2016-01-06 | 2016-03-13 | BENDAMUSTINE + RITUXIMAB | 2 | Y | 260024397 | BENDAMUSTINE + RITUXIMAB |
| 260006710 | 260004856 | 1.66 | 74 | Disease modification (D) | 2018-08-09 | 2018-08-27 | BENDAMUSTINE + RITUXIMAB | N | N | 260024397 | BENDAMUSTINE + RITUXIMAB |
| 260006711 | 260004857 | 1.85 | 66.7 | Palliative (P) | 2018-06-18 | 2018-07-07 | BENDAMUSTINE + RITUXIMAB | N | N | 260024400 | BENDAMUSTINE + RITUXIMAB |
| 260006712 | 260004858 | 1.77 | 66.1 | Palliative (P) | 2017-06-30 | 2017-08-17 | Bendamustine+Rituximab (1st Course) | N | N | 260024401 | BENDAMUSTINE + RITUXIMAB |
| 260006713 | 260004858 | 1.55 | 63 | Disease modification (D) | 2014-10-23 | 2014-10-23 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024401 | BENDAMUSTINE + RITUXIMAB |
| 260006714 | 260004858 | 1.71 | null | null | null | 2017-04-02 | BENDAMUSTINE + RITUXIMAB | N | N | 260024401 | BENDAMUSTINE + RITUXIMAB |
| 260006715 | 260004858 | 1.57 | 52.75 | Palliative (P) | 2016-01-14 | 2016-01-22 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260024401 | BENDAMUSTINE + RITUXIMAB |
| 260006716 | 260004859 | null | 72.1 | Palliative (P) | null | 2017-08-05 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260024407 | BENDAMUSTINE + RITUXIMAB |
| 260006717 | 260011361 | 1.6 | 72 | Palliative (P) | 2016-11-26 | 2016-12-13 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260024409 | BENDAMUSTINE + RITUXIMAB |
| 260006718 | 260011361 | 1.75 | 77 | Disease modification (D) | 2016-12-26 | 2016-12-26 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 260024409 | BENDAMUSTINE + RITUXIMAB |
| 260006719 | 260011361 | 1.94 | 85.5 | Curative (C) | 2014-12-21 | 2014-12-21 | BENDAMUSTINE + RITUXIMAB | N | N | 260024409 | BENDAMUSTINE + RITUXIMAB |
| 260006720 | 260004860 | null | null | Disease modification (D) | 2016-01-29 | 2016-02-02 | BENDAMUSTINE + RITUXIMAB | 02 | null | 260024414 | BENDAMUSTINE + RITUXIMAB |
| 260006721 | 260004860 | 1.59 | 56.2 | Palliative (P) | 2013-06-27 | 2013-07-17 | BENDAMUSTINE + RITUXIMAB | N | null | 260024414 | BENDAMUSTINE + RITUXIMAB |
| 260006722 | 260004860 | 1.76 | 84 | Disease modification (D) | null | 2015-04-30 | BENDAMUSTINE + RITUXIMAB | N | N | 260024414 | BENDAMUSTINE + RITUXIMAB |
| 260006723 | 260004860 | 1.84 | 85.5 | Adjuvant (A) | 2017-04-06 | 2017-04-15 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260024414 | BENDAMUSTINE + RITUXIMAB |
| 260006724 | 260004860 | 1.58 | 54 | Disease modification (D) | 2016-06-27 | 2016-07-12 | BENDAMUSTINE + RITUXIMAB | N | N | 260024414 | BENDAMUSTINE + RITUXIMAB |
| 260006725 | 260004861 | 1.72 | 98 | Curative (C) | 2016-07-01 | 2016-07-05 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024421 | BENDAMUSTINE + RITUXIMAB |
| 260006726 | 260004861 | null | 87 | Curative (C) | 2015-08-12 | 2015-08-14 | BENDAMUSTINE + RITUXIMAB | N | N | 260024421 | BENDAMUSTINE + RITUXIMAB |
| 260006727 | 260004862 | 1.76 | 92.5 | Palliative (P) | null | 2013-06-24 | BENDAMUSTINE + RITUXIMAB | null | N | 260024423 | BENDAMUSTINE + RITUXIMAB |
| 260006728 | 260004862 | 1.79 | 85.3 | Disease modification (D) | 2015-03-04 | 2015-03-12 | BENDAMUSTINE + RITUXIMAB | N | N | 260024423 | BENDAMUSTINE + RITUXIMAB |
| 260006729 | 260004863 | 1.68 | 96.5 | Palliative (P) | 2017-12-02 | 2017-12-07 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260024425 | BENDAMUSTINE + RITUXIMAB |
| 260006730 | 260011365 | 1.59 | 41 | Disease modification (D) | null | 2017-02-04 | BENDAMUSTINE + RITUXIMAB | N | N | 260024430 | BENDAMUSTINE + RITUXIMAB |
| 260006731 | 260011365 | null | 61.8 | null | 2016-04-18 | 2016-04-18 | BENDAMUSTINE + RITUXIMAB | N | null | 260024430 | BENDAMUSTINE + RITUXIMAB |
| 260006732 | 260004864 | null | 101.7 | null | 2018-05-24 | 2018-05-24 | BENDAMUSTINE + RITUXIMAB | 99 | N | 260024437 | BENDAMUSTINE + RITUXIMAB |
| 260006733 | 260004864 | 1.66 | 78 | Palliative (P) | 2017-10-14 | 2017-10-14 | BENDAMUSTINE + RITUXIMAB | N | N | 260024437 | BENDAMUSTINE + RITUXIMAB |
| 260006734 | 260004864 | null | null | Palliative (P) | null | 2013-07-07 | BENDAMUSTINE + RITUXIMAB | null | N | 260024437 | BENDAMUSTINE + RITUXIMAB |
| 260006735 | 260004865 | 1.76 | 140 | Disease modification (D) | 2017-12-20 | 2017-12-30 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260024442 | BENDAMUSTINE + RITUXIMAB |